3,3',5-Triiodothyroacetic acid

Target genes for 3,3',5-Triiodothyroacetic acid is obtained based on ToxCast assay component endpoints.
Chemical nameGene identifierToxCast assay component endpoint name
3,3',5-Triiodothyroacetic acidCCL26BSK_4H_Eotaxin3_down
3,3',5-Triiodothyroacetic acidPDE10ANVS_ENZ_hPDE10
3,3',5-Triiodothyroacetic acidCOL3A1BSK_hDFCGF_CollagenIII_down
3,3',5-Triiodothyroacetic acidEDNRBNVS_GPCR_hETB
3,3',5-Triiodothyroacetic acidESR1OT_ER_ERaERa_1440
3,3',5-Triiodothyroacetic acidESR1ATG_ERa_TRANS_up
3,3',5-Triiodothyroacetic acidESR1TOX21_ERa_BLA_Antagonist_ratio
3,3',5-Triiodothyroacetic acidESR1TOX21_ERa_LUC_VM7_Agonist
3,3',5-Triiodothyroacetic acidESR1ACEA_ER_80hr
3,3',5-Triiodothyroacetic acidESR1OT_ER_ERaERb_1440
3,3',5-Triiodothyroacetic acidESR1ATG_ERE_CIS_up
3,3',5-Triiodothyroacetic acidESR1OT_ER_ERaERa_0480
3,3',5-Triiodothyroacetic acidESR1NVS_NR_hER
3,3',5-Triiodothyroacetic acidESR1OT_ER_ERaERb_0480
3,3',5-Triiodothyroacetic acidESR2OT_ER_ERaERb_0480
3,3',5-Triiodothyroacetic acidESR2OT_ER_ERaERb_1440
3,3',5-Triiodothyroacetic acidESR2TOX21_ERb_BLA_Antagonist_ratio
3,3',5-Triiodothyroacetic acidESRRATOX21_ERR_Antagonist
3,3',5-Triiodothyroacetic acidESRRATOX21_PGC_ERR_Antagonist
3,3',5-Triiodothyroacetic acidFOSATG_AP_1_CIS_up
3,3',5-Triiodothyroacetic acidNR3C1NVS_NR_hGR
3,3',5-Triiodothyroacetic acidNR3C1TOX21_GR_BLA_Antagonist_ratio
3,3',5-Triiodothyroacetic acidHLA-DRABSK_BE3C_HLADR_down
3,3',5-Triiodothyroacetic acidHSF1ATG_HSE_CIS_up
3,3',5-Triiodothyroacetic acidIL1ABSK_BE3C_IL1a_down
3,3',5-Triiodothyroacetic acidIL6BSK_CASM3C_IL6_down
3,3',5-Triiodothyroacetic acidCXCL10BSK_KF3CT_IP10_down
3,3',5-Triiodothyroacetic acidCXCL10BSK_BE3C_IP10_down
3,3',5-Triiodothyroacetic acidARACEA_AR_antagonist_80hr
3,3',5-Triiodothyroacetic acidARTOX21_AR_BLA_Antagonist_ratio
3,3',5-Triiodothyroacetic acidJUNATG_AP_1_CIS_up
3,3',5-Triiodothyroacetic acidJUNTOX21_AP1_BLA_Agonist_ratio
3,3',5-Triiodothyroacetic acidFOSTOX21_AP1_BLA_Agonist_ratio
3,3',5-Triiodothyroacetic acidSMAD1ATG_BRE_CIS_up
3,3',5-Triiodothyroacetic acidCXCL9BSK_BE3C_MIG_down
3,3',5-Triiodothyroacetic acidMMP1BSK_BE3C_MMP1_up
3,3',5-Triiodothyroacetic acidMMP1BSK_hDFCGF_MMP1_down
3,3',5-Triiodothyroacetic acidMMP9BSK_KF3CT_MMP9_down
3,3',5-Triiodothyroacetic acidMTF1ATG_MRE_CIS_up
3,3',5-Triiodothyroacetic acidNFE2L2TOX21_ARE_BLA_agonist_ratio
3,3',5-Triiodothyroacetic acidNFE2L2ATG_NRF2_ARE_CIS_up
3,3',5-Triiodothyroacetic acidNTRK1NVS_ENZ_hTrkA
3,3',5-Triiodothyroacetic acidNR4A2ATG_NURR1_TRANS_up
3,3',5-Triiodothyroacetic acidSERPINE1BSK_hDFCGF_PAI1_down
3,3',5-Triiodothyroacetic acidSERPINE1BSK_BE3C_PAI1_down
3,3',5-Triiodothyroacetic acidLEF1ATG_TCF_b_cat_CIS_dn
3,3',5-Triiodothyroacetic acidPGRNVS_NR_hPR
3,3',5-Triiodothyroacetic acidPGRTOX21_PR_BLA_Antagonist_ratio
3,3',5-Triiodothyroacetic acidPLATBSK_BE3C_tPA_down
3,3',5-Triiodothyroacetic acidPLAUBSK_BE3C_uPA_down
3,3',5-Triiodothyroacetic acidPLAURBSK_4H_uPAR_down
3,3',5-Triiodothyroacetic acidPOU2F1ATG_Oct_MLP_CIS_up
3,3',5-Triiodothyroacetic acidPPARAATG_PPRE_CIS_up
3,3',5-Triiodothyroacetic acidPPARDATG_PPRE_CIS_up
3,3',5-Triiodothyroacetic acidPPARGATG_PPARg_TRANS_up
3,3',5-Triiodothyroacetic acidPPARGATG_PPRE_CIS_up
3,3',5-Triiodothyroacetic acidPPARGTOX21_PPARg_BLA_antagonist_ratio
3,3',5-Triiodothyroacetic acidRARAATG_RARa_TRANS_dn
3,3',5-Triiodothyroacetic acidRARBATG_RARb_TRANS_dn
3,3',5-Triiodothyroacetic acidRORAATG_RORE_CIS_up
3,3',5-Triiodothyroacetic acidRORBATG_RORb_TRANS_up
3,3',5-Triiodothyroacetic acidRORBATG_RORE_CIS_up
3,3',5-Triiodothyroacetic acidRORCATG_RORE_CIS_up
3,3',5-Triiodothyroacetic acidRXRATOX21_RXR_BLA_Agonist_ratio
3,3',5-Triiodothyroacetic acidRXRAOT_NURR1_NURR1RXRa_0480
3,3',5-Triiodothyroacetic acidRXRBATG_RXRb_TRANS_up
3,3',5-Triiodothyroacetic acidSELEBSK_SAg_Eselectin_up
3,3',5-Triiodothyroacetic acidSLC5A5NIS_RAIU_inhibition
3,3',5-Triiodothyroacetic acidSREBF1ATG_SREBP_CIS_up
3,3',5-Triiodothyroacetic acidAURKANVS_ENZ_hAurA
3,3',5-Triiodothyroacetic acidTCF7ATG_TCF_b_cat_CIS_dn
3,3',5-Triiodothyroacetic acidTCF7L2ATG_TCF_b_cat_CIS_dn
3,3',5-Triiodothyroacetic acidTFAP2AATG_AP_2_CIS_dn
3,3',5-Triiodothyroacetic acidTFAP2BATG_AP_2_CIS_dn
3,3',5-Triiodothyroacetic acidTGFB1BSK_KF3CT_TGFb1_down
3,3',5-Triiodothyroacetic acidTHRAATG_THRa1_TRANS_up
3,3',5-Triiodothyroacetic acidTNFBSK_LPS_TNFa_up
3,3',5-Triiodothyroacetic acidTP53TOX21_p53_BLA_p5_ratio
3,3',5-Triiodothyroacetic acidTP53TOX21_p53_BLA_p3_ratio
3,3',5-Triiodothyroacetic acidTP53TOX21_p53_BLA_p1_ratio
3,3',5-Triiodothyroacetic acidTP53TOX21_p53_BLA_p2_ratio
3,3',5-Triiodothyroacetic acidTP53ATG_p53_CIS_up
3,3',5-Triiodothyroacetic acidTP53TOX21_p53_BLA_p4_ratio
3,3',5-Triiodothyroacetic acidVCAM1BSK_4H_VCAM1_down
3,3',5-Triiodothyroacetic acidVCAM1BSK_CASM3C_VCAM1_down
3,3',5-Triiodothyroacetic acidVDRATG_VDRE_CIS_up
3,3',5-Triiodothyroacetic acidTCF7L1ATG_TCF_b_cat_CIS_dn
3,3',5-Triiodothyroacetic acidTFAP2DATG_AP_2_CIS_dn
3,3',5-Triiodothyroacetic acidNR1I2ATG_PXRE_CIS_up
3,3',5-Triiodothyroacetic acidNR1I2ATG_PXR_TRANS_up
3,3',5-Triiodothyroacetic acidNR1H4NVS_NR_hFXR_Antagonist
3,3',5-Triiodothyroacetic acidNR1H4TOX21_FXR_BLA_antagonist_ratio
3,3',5-Triiodothyroacetic acidNR1H4OT_FXR_FXRSRC1_1440
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.